North Star Investment Management Corp. Has $114,000 Stake in iShares Nasdaq Biotechnology ETF (IBB)

Share on StockTwits

North Star Investment Management Corp. raised its holdings in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 21.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,180 shares of the financial services provider’s stock after acquiring an additional 210 shares during the quarter. North Star Investment Management Corp.’s holdings in iShares Nasdaq Biotechnology ETF were worth $114,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also modified their holdings of the company. MML Investors Services LLC raised its position in shares of iShares Nasdaq Biotechnology ETF by 47.8% during the 3rd quarter. MML Investors Services LLC now owns 83,393 shares of the financial services provider’s stock valued at $10,169,000 after purchasing an additional 26,971 shares during the period. Albion Financial Group UT increased its holdings in iShares Nasdaq Biotechnology ETF by 1.1% in the 2nd quarter. Albion Financial Group UT now owns 98,383 shares of the financial services provider’s stock valued at $10,804,000 after acquiring an additional 1,104 shares during the last quarter. Cypress Wealth Services LLC bought a new stake in iShares Nasdaq Biotechnology ETF in the 3rd quarter valued at $208,000. Pinnacle Financial Partners Inc. increased its holdings in iShares Nasdaq Biotechnology ETF by 46.4% in the 3rd quarter. Pinnacle Financial Partners Inc. now owns 4,282 shares of the financial services provider’s stock valued at $522,000 after acquiring an additional 1,357 shares during the last quarter. Finally, Private Capital Advisors Inc. increased its holdings in iShares Nasdaq Biotechnology ETF by 0.9% in the 3rd quarter. Private Capital Advisors Inc. now owns 80,481 shares of the financial services provider’s stock valued at $9,814,000 after acquiring an additional 724 shares during the last quarter. Institutional investors and hedge funds own 64.33% of the company’s stock.

iShares Nasdaq Biotechnology ETF stock opened at $107.50 on Thursday. iShares Nasdaq Biotechnology ETF has a twelve month low of $89.01 and a twelve month high of $122.97.

WARNING: “North Star Investment Management Corp. Has $114,000 Stake in iShares Nasdaq Biotechnology ETF (IBB)” was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://www.tickerreport.com/banking-finance/4067857/north-star-investment-management-corp-has-114000-stake-in-ishares-nasdaq-biotechnology-etf-ibb.html.

About iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Story: Conference Calls

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Dash  Hits Market Cap of $614.45 Million
Dash Hits Market Cap of $614.45 Million
Bell Asset Management Ltd Has $8.99 Million Holdings in American Express
Bell Asset Management Ltd Has $8.99 Million Holdings in American Express
Barton Investment Management Has $23.40 Million Position in Blackline Inc
Barton Investment Management Has $23.40 Million Position in Blackline Inc
Zacks: Cumulus Media Inc  Receives Average Recommendation of “Strong Buy” from Analysts
Zacks: Cumulus Media Inc Receives Average Recommendation of “Strong Buy” from Analysts
Zacks: Analysts Set $25.00 Target Price for Global Net Lease Inc
Zacks: Analysts Set $25.00 Target Price for Global Net Lease Inc
Litecoin  Price Down 1.7% Over Last 7 Days
Litecoin Price Down 1.7% Over Last 7 Days


Leave a Reply

© 2006-2019 Ticker Report